ProciseDx Announces the First FDA-cleared Therapeutic Drug Monitoring Tests for Biologic Drugs, Humira®, Remicade®, and their BiosimilarsBy / 03/10/2023 ProciseDx Inc. announces that it has been granted de novo FDA clearance for the therapeutic drug monitoring (TDM).